APR:NSD-Apria Inc (USD)

COMMON STOCK | Medical Instruments & Supplies | NSD

Last Closing Price

USD 37.50

Change

0.00 (0.00)%

Market Cap

USD 1.34B

Volume

0.44M

Avg Analyst Target

N/A

Avg User Target

USD
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

APR Stock Forecast & Price:
Based on the Apria Inc stock forecasts from 0 analysts, the average analyst target price for Apria Inc is not available over the next 12 months. Apria Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Apria Inc is Slightly Bullish , which is based on 3 positive signals and 2 negative signals. At the last closing, Apria Inc’s stock price was USD 37.50. Apria Inc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +19.81% over the last year.

About Apria Inc (APR:NSD)

Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy ...Read More

Company Website : https://www.apria.com

Address : 7353 Company Drive, Indianapolis, IN, United States, 46237

Employees : 6,080

Fiscal Year End : December

Currency: USD

Country : USA

Technical Indicators

Beta : -0.47

52 Week High : 40.00

Short Ratio : 4.60

52 Week Low : 27.89

Shorted Shares : 2,192,735

200 Day Moving Average : 34.13

Shorted Shares Previous Month : 1,449,045

50 Day Moving Average : 37.37

Shares Held By Insiders : 2.58%

Short Percentage : 10.63%

Shares Held by Institutions : 106.30%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-08-09 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ISRG Intuitive Surgical Inc

-6.25 (-2.61%)

 USD85.40B 61.63 40.39
HOLX Hologic Inc

-1.37 (-1.88%)

 USD18.17B 12.23 7.74
RGEN Repligen Corporation

-5.61 (-2.24%)

 USD13.90B 89.77 53.18
MASI Masimo Corporation

-6.44 (-4.17%)

 USD8.58B 39.24 25.09
NVCR Novocure Ltd

-0.86 (-1.11%)

 USD8.12B 1,480.87 -158.86
XRAY Dentsply Sirona Inc

-0.68 (-1.84%)

 USD7.94B 21.93 10.96
QDEL Quidel Corporation

-3.83 (-4.24%)

 USD6.30B 4.20 4.13
AZTA Azenta Inc

-5.16 (-7.48%)

 USD5.17B 2.33 162.06
ICUI ICU Medical Inc

-21.79 (-11.58%)

 USD4.29B 85.95 32.09
STAA STAAR Surgical Company

-4.83 (-5.51%)

 USD4.04B 145.71 94.64

ETFs Containing APR

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Instruments & Supplies)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.03% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.03% N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 22.91% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.91% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.87% 26% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.87% 23% F 47% F
Risk Return Profile  
Volatility (Standard Deviation) 16.89% 97% A+ 78% C+
Risk Adjusted Return 58.41% 37% F 58% F
Market Capitalization 1.34B N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Instruments & Supplies)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 22.59 N/A N/A N/A N/A
Price/Book Ratio 33.73 N/A N/A N/A N/A
Price / Cash Flow Ratio 6.32 N/A N/A N/A N/A
EV/EBITDA 7.25 N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 96.92% N/A N/A N/A N/A
Return on Invested Capital 18.58% N/A N/A N/A N/A
Return on Assets 9.09% N/A N/A N/A N/A
Debt to Equity Ratio 858.23% N/A N/A N/A N/A
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio 4.60 N/A N/A N/A N/A
Short Percent 10.63% N/A N/A N/A N/A
Beta -0.47 N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date
New Post

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.